ATHN 9: Severe VWD Natural History Study

Active, not recruitingOBSERVATIONAL
Enrollment

108

Participants

Timeline

Start Date

June 18, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

July 30, 2026

Conditions
Von Willebrand Diseases
Trial Locations (22)

15213

Hemophilia Center of Western Pennsylvania, Pittsburgh

19104

Pennsylvania Comprehensive Hemophilia and Thrombophilia Program / Hospital of the University of Pennsylvania, Philadelphia

30322

Children's Healthcare of Atlanta/Emory, Atlanta

32610

University of Florida Hemophilia Treatment Center, Gainesville

37212

Vanderbilt University Medical Center, Nashville

38119

University of Tennessee, University Clinical Health (Memphis), Memphis

43205

Nationwide Children's Hospital Columbus, Columbus

46260

Indiana Hemophilia and Thrombosis Center (IHTC), Indianapolis

48109

University of Michigan Hemophilia and Coagulation Disorders, Ann Arbor

48201

Children's Hospital of Michigan Hemostasis and Thrombosis Center, Detroit

48823

Michigan State University Center for Bleeding and Clotting Disorders, East Lansing

53201

Versiti - Blood Center of Wisconsin, Milwaukee

54311

Hemophilia Outreach Center, Green Bay

55905

Mayo Comprehensive Hemophilia Center, Rochester

61615

Bleeding and Clotting Disorders Institute, Peoria

63110

Washington University Center for Treatment of Bleeding and Blood Clotting Disorders, St Louis

70112

Louisiana Center for Bleeding and Clotting Disorders, New Orleans

80045

University of Colorado Denver Hemophilia and Thrombosis Center, Aurora

91239

Oregon Health, Portland

92868

Center for Inherited Blood Disorders, Orange

06030

Connecticut Bleeding and Clotting Disorders Center, Farmington

02903

Rhode Island Hemostasis & Thrombosis Center, Providence

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Takeda

INDUSTRY

lead

American Thrombosis and Hemostasis Network

NETWORK